Also known as 1,4-Dimethyl-2,3-benzphenanthrene, 9,10-Dimethylbenz(a)anthracene, 7,12-Dimethylbenzanthrancene, 7,12-Dimethylbenzanthracene, 7,12-Dimethyl-1:2-benz(a)anthracene, 7,12-Dimethyl-1,2-benzanthracene
via PubMed
'7,12-Dimethylbenz[a]anthracene (DMBA') is an immunosuppressor and a powerful organ-specific laboratory carcinogen. DMBA is widely used in many research laboratories studying cancer. DMBA serves as a tumor initiator. Tumor promotion can be induced with treatments of 12-O-tetradecanoylphorbol-13-acetate (TPA) in some models of two-stage carcinogenesis. This allows for a greatly accelerated rate of tumor growth, making many cancer studies possible.
via Wikidata · CC0
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).